Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.0100 (0.60%)
NASDAQ· Last Trade: Jun 11th, 7:30 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors